检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:李琳娜[1] 王利娟[1] 何可可[2] 李海成[1] 何金花[1] 蒋建伟[1] 刘誉[1]
机构地区:[1]暨南大学医学院生物化学教研室,广东广州510632 [2]中山大学第三附属医院放射科,广东广州510630
出 处:《暨南大学学报(自然科学与医学版)》2008年第2期125-129,共5页Journal of Jinan University(Natural Science & Medicine Edition)
基 金:暨南大学引进人才启动基金资助项目(51204004);广州市科技计划资助项目(2002J1-C0361)
摘 要:目的:研究晚期糖基化终产物(advanced glycation end products,AGEs)对人肾小管上皮细胞株(HKC)的细胞毒性作用。方法:以体外培养的HKC细胞为研究对象,采用MTT法测定不同质量浓度(0、50、100、200、400、800 mg/L)AGEs对HKC生长的抑制作用,应用流式细胞仪分析细胞的凋亡情况,RT-PCR分析不同浓度AGEs处理HKC后其IL-1β,TNF-α,HMGB1基因的转录水平变化。结果:AGEs质量浓度为100、200、400、800 mg/L时分别刺激HKC细胞24和48 h后,均能显著抑制细胞的增殖,且抑制作用具有时间和剂量依赖性。流式细胞仪分析发现,AGEs能促使HKC发生凋亡,凋亡率亦随AGEs浓度的增高而增加。RT-PCR方法检测显示,AGEs使HKC细胞IL-1β、TNF-α、HMGB1基因的表达上调。结论:AGEs可抑制人肾小管上皮细胞的增殖,并诱导其发生凋亡,此作用可能与其上调IL-1β、TNF-α和HMGB1基因的表达有关。Aim:To investigate the cytotoxicity of human renal tubular epithelial cells(HKC) induced by advanced glycation end products(AGEs). Methods: The proliferative inhibition of HKC by AGEs at different concentrations (0,50,100,200,400,800 mg/L) was accessed by using MTF assay. Cell apoptosis was analyzed by flow cytometry. The mRNA levels of IL-1β, TNF-α and HMGB1 were determined by RT-PCR. Results: AGEs at 100,200,400,800 mg/L significantly inhibited proliferation of HKC after incubation with AGEs for 24 and 48 h, which showed good time-and dose-dependent fashions. AGEs were also found to cause apoptosis in HKC. The flow cytometry analysis showed that AGEs increased the proportion of apoptotic cells in a dose-dependent manner, while RT-PCR analysis demonstrated that the mRNA expression levels of IL-1β, TNF-αand HMGB1 in HKC cells were up-regulated by AGEs. Conclusion:AGEs can inhibit proliferation and also induce apoptosis in HKC. These effects may be related to the up-regulated expression of IL-1β, TNF-α and HMGB1 genes.
分 类 号:R318.16[医药卫生—生物医学工程]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.117